These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38303726)

  • 1. Glioblastoma extracellular vesicles modulate immune PD-L1 expression in accessory macrophages upon radiotherapy.
    Schweiger MW; Amoozgar Z; Repiton P; Morris R; Maksoud S; Hla M; Zaniewski E; Noske DP; Haas W; Breyne K; Tannous BA
    iScience; 2024 Feb; 27(2):108807. PubMed ID: 38303726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells.
    Musatova OE; Rubtsov YP
    Front Cell Dev Biol; 2023; 11():1060000. PubMed ID: 36960410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1.
    Jung MY; Aibaidula A; Brown DA; Himes BT; Cumba Garcia LM; Parney IF
    Neurooncol Adv; 2022; 4(1):vdac017. PubMed ID: 35990703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
    Yekula A; Yekula A; Muralidharan K; Kang K; Carter BS; Balaj L
    Front Immunol; 2019; 10():3137. PubMed ID: 32038644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
    Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
    Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.
    Schatz J; Ladinig A; Fietkau R; Putz F; Gaipl US; Frey B; Derer A
    Strahlenther Onkol; 2023 Dec; 199(12):1140-1151. PubMed ID: 36480032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
    Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
    Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
    [No Abstract]   [Full Text] [Related]  

  • 8. Extracellular vesicles produced by irradiated endothelial or Glioblastoma stem cells promote tumor growth and vascularization modulating tumor microenvironment.
    Castellani G; Buccarelli M; D'Alessandris QG; Ilari R; Cappannini A; Pedini F; Boe A; Lulli V; Parolini I; Giannetti S; Biffoni M; Zappavigna V; Marziali G; Pallini R; Ricci-Vitiani L
    Cancer Cell Int; 2024 Feb; 24(1):72. PubMed ID: 38347567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint Inhibition in GBM Primed with Radiation by Engineered Extracellular Vesicles.
    Tian T; Liang R; Erel-Akbaba G; Saad L; Obeid PJ; Gao J; Chiocca EA; Weissleder R; Tannous BA
    ACS Nano; 2022 Feb; 16(2):1940-1953. PubMed ID: 35099172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages.
    Tankov S; Petrovic M; Lecoultre M; Espinoza F; El-Harane N; Bes V; Chliate S; Bedoya DM; Jordan O; Borchard G; Migliorini D; Dutoit V; Walker PR
    Cell Commun Signal; 2024 Feb; 22(1):144. PubMed ID: 38389103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain.
    van der Vos KE; Abels ER; Zhang X; Lai C; Carrizosa E; Oakley D; Prabhakar S; Mardini O; Crommentuijn MH; Skog J; Krichevsky AM; Stemmer-Rachamimov A; Mempel TR; El Khoury J; Hickman SE; Breakefield XO
    Neuro Oncol; 2016 Jan; 18(1):58-69. PubMed ID: 26433199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking through the glioblastoma micro-environment via extracellular vesicles.
    Simon T; Jackson E; Giamas G
    Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.
    de Vrij J; Maas SL; Kwappenberg KM; Schnoor R; Kleijn A; Dekker L; Luider TM; de Witte LD; Litjens M; van Strien ME; Hol EM; Kroonen J; Robe PA; Lamfers ML; Schilham MW; Broekman ML
    Int J Cancer; 2015 Oct; 137(7):1630-42. PubMed ID: 25802036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial Extracellular Vesicles as Modulators of Brain Microenvironment in Glioma.
    Catalano M; Serpe C; Limatola C
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
    Kiyokawa J; Kawamura Y; Ghouse SM; Acar S; Barçın E; Martínez-Quintanilla J; Martuza RL; Alemany R; Rabkin SD; Shah K; Wakimoto H
    Clin Cancer Res; 2021 Feb; 27(3):889-902. PubMed ID: 33257429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages.
    Liu X; Li Z; Sun J; Zhang Z; Li W
    BMC Cancer; 2023 Mar; 23(1):259. PubMed ID: 36941554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy.
    Jennrich S; Pelzer M; Tertel T; Koska B; Vüllings M; Thakur BK; Jendrossek V; Timmermann B; Giebel B; Rudner J
    Front Oncol; 2022; 12():947439. PubMed ID: 36203458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors.
    Musca B; Russo MG; Tushe A; Magri S; Battaggia G; Pinton L; Bonaudo C; Della Puppa A; Mandruzzato S
    Front Immunol; 2023; 14():1236824. PubMed ID: 37936683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
    Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.